---

Journal of Clinical Oncology

ルーム内検索
全38件   1  2 次の20件>>
ID
トピック名
閲覧/投稿
最新投稿
作成
360 【臨床研究】Health-Related Quality of Life Results From the Open-Label, Randomized, Phase III ASPIRE Trial Evaluating Carfilzomib, Lenalidomide, and Dexamethasone Versus Lenalidomide and Dexamethasone in Patients With Relapsed Multiple Myeloma. 327 / 0
2016-10-20
KMF CRC
359 【コメント】Optimizing Treatment for Elderly Patients With Newly Diagnosed Multiple Myeloma: A Personalized Approach. 300 / 0
2016-10-20
KMF CRC
358 【臨床研究】Statins Are Associated With Reduced Mortality in Multiple Myeloma. 307 / 0
2016-10-20
KMF CRC
357 【臨床研究】Nivolumab in Patients With Relapsed or Refractory Hematologic Malignancy: Preliminary Results of a Phase Ib Study. 338 / 0
2016-10-20
KMF CRC
356 【臨床研究】Updated Outcomes and Impact of Age With Lenalidomide and Low-Dose Dexamethasone or Melphalan, Prednisone, and Thalidomide in the Randomized, Phase III FIRST Trial. 376 / 0
2016-10-20
KMF CRC
355 【レビュー】International Myeloma Working Group Recommendations for the Diagnosis and Management of Myeloma-Related Renal Impairment. 211 / 0
2016-10-20
KMF CRC
354 【臨床研究】Cardiovascular Disease Among Survivors of Adult-Onset Cancer: A Community-Based Retrospective Cohort Study. 193 / 0
2016-10-17
KMF CRC
353 【レビュー】Financial Concerns About Participation in Clinical Trials Among Patients With Cancer. 183 / 0
2016-10-17
KMF CRC
255 【レビュー】Continuous Therapy Versus Fixed Duration of Therapy in Patients With Newly Diagnosed Multiple Myeloma. 677 / 0
2015-10-19
KMF CRC
254 【臨床研究】Mutational Spectrum, Copy Number Changes, and Outcome: Results of a Sequencing Study of Patients With Newly Diagnosed Myeloma. 623 / 0
2015-10-19
KMF CRC
253 【レビュー】Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group. 879 / 0
2015-10-19
KMF CRC
252 【臨床研究】Community-Based Phase IIIB Trial of Three UPFRONT Bortezomib-Based Myeloma Regimens. 474 / 0
2015-10-19
KMF CRC
251 【臨床研究】Translocation t(11;14) is associated with adverse outcome in patients with newly diagnosed AL amyloidosis when treated with bortezomib-based regimens. 615 / 0
2015-10-19
KMF CRC
250 【レビュー】Role of magnetic resonance imaging in the management of patients with multiple myeloma: a consensus statement. 270 / 0
2015-10-19
KMF CRC
249 【レビュー】Dilemmas in treating smoldering multiple myeloma. 268 / 0
2015-10-19
KMF CRC
178 【臨床研究】Aprepitant, granisetron, and dexamethasone for prevention of chemotherapy-induced nausea and vomiting after high-dose melphalan in autologous transplantation for multiple myeloma: results of a randomized, placebo-controlled phase III trial. 507 / 0
2015-02-25
KMF CRC
177 【臨床研究】Front-line transplantation program with lenalidomide, bortezomib, and dexamethasone combination as induction and consolidation followed by lenalidomide maintenance in patients with multiple myeloma: a phase II study by the Intergroupe Francophone du 436 / 0
2015-02-25
KMF CRC
176 【臨床研究】Increased serum free light chains precede the presentation of immunoglobulin light chain amyloidosis. 429 / 0
2015-02-25
KMF CRC
175 【レビュー】Multiple myeloma in the older adult: better prospects, more challenges. 435 / 0
2015-02-25
KMF CRC
160 【臨床研究】Combination of International Scoring System 3, High Lactate Dehydrogenase, and t(4;14) and/or del(17p) Identifies Patients With Multiple Myeloma (MM) Treated With Front-Line Autologous Stem-Cell Transplantation at High Risk of Early MM Progression–R 454 / 0
2014-08-09
KMF CRC
全38件   1  2 次の20件>>